Diazoxide-resistant hyperinsulinism

MONDO:0017186

Diazoxide-resistant hyperinsulism (DRH) is form of congenital isolated hyperinsulism caused by an abnormal insulin production by B-cells in the pancreas that can be diffuse or focal and is characterized by an excessive/ uncontrolled insulin secretion (inappropriate for the level of glycemia), recurrent episodes of profound hypoglycemia and resistance to medical management with diazoxide.

Also known as: diazoxide-resistant hyperinsulinemic hypoglycemia

0 clinical trials for this condition and its sub-types, 0 tagged with Diazoxide-resistant hyperinsulinism itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Congenital isolated hyperinsulinism (2)

Sub-types of Diazoxide-resistant hyperinsulinism

Diazoxide-resistant diffuse hyperinsulinism 0 trials
2 sub-types
- Autosomal recessive hyperinsulinism due to Kir6.2 deficiency 0 trials
- Autosomal recessive hyperinsulinism due to SUR1 deficiency 0 trials
Diazoxide-resistant focal hyperinsulinism 0 trials
2 sub-types
- Diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency 0 trials
- Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency 0 trials

Including sub-types (0) Tagged with Diazoxide-resistant hyperinsulinism (0)

We haven't found any trials for this condition yet. Follow it to get notified when new trials appear.